- Listed funds and REITs raise £5bn initial and follow-on capital in H1 2017
- 9 fund IPOs raise £1.4bn in H1 2017, five fold increase on H1 2016
- Existing funds and REITs raise £3.6bn in further capital in H1 2017
- US fund managers list funds worth over £3.5bn in London
- London attracts growing numbers of international fund managers across diversified range of funds
London Stock Exchange today announces that nine fund IPOs have listed on its markets to date in 2017, raising £1.4 billion. London listed funds have also raised £3.6 billion in further capital in the first half of the year.
London continues to be an attractive market for international fund managers, particularly from the United States. Since the start of the year, US fund managers have listed funds worth over £3.5 billion in London.
Most notable is the increasing diversified nature of the funds, from microcap, supporting SMEs, and real estate specific funds for social housing, private rented sector and student property, to life sciences debt funds, demonstrating London Stock Exchange’s role in funding all sectors of the economy. A landmark for the UK fund market in 2017, Pershing Square Holdings, a close-ended investment company, successfully listed its £2.9 billion fund, transferring its existing trading line from Amsterdam.
Darko Hajdukovic, Head of Analytics, Fixed Income and Funds, Primary Markets London Stock Exchange Group:
“This year’s surge in fund listings demonstrates London’s ability to finance a variety of issuers from around the world, using diverse and often innovative strategies. Particularly encouraging is the success of US-based fund managers accessing London’s deep pool of international capital, with over £3.5 billion listed in London by US fund managers to date in 2017.
“A number of this year’s funds have raised capital to invest in new asset classes, demonstrating our role in funding all sectors of the real economy. BioPharma Credit raised over £600 million, becoming the first London listed fund to specialise in debt financing for the life sciences industry.”
Key statistics:
Notable listings in H1 2017 include:
- BioPharma Credit, the first London listed fund specialising in debt financing for life sciences industry, floating on the Specialist Fund Segment of the Main Market;
- Pershing Square Holdings, a close-ended investment company, successfully listing its £2.9 billion fund, which was originally listed in Amsterdam;
- PRS REIT, the first listed fund to focus solely on Private Rented Sector properties, raising £250 million and
- Impact Healthcare Trust raising £160 million to invest in a portfolio of care homes.
- 461 funds are quoted on London Stock Exchange
- The largest fund by money raised to date in 2017 is BioPharma Credit plc, which raised £608 million in March
More information on the Specialist Fund Segment can be found at: www.londonstockexchange.com/companies-and-advisors/sfm/home/sfm.htm
